The new subsidiary will be engaged on marketing and selling Astellas‘ global products like Omnic and OmnicOCAS as a tretamnet for functional symptoms of benign prostatic hyperplasia.
Additionally, the company will also market Vesicare for the treatment of overactive bladder, Protopic for the treatment of atopic dermatitis and Prograf/ Advagraf, an immunosuppressant.
Earlier in 2009, the company has established wholly-owned subsidiaries in Romania and Bulgaria.
Astellas South East Europe will manage the business in Romania and Bulgaria, as well as Slovenia, Croatia, and some operations in Bosnia-Herzegovina, as one regional organisation.